Form 4 for IDXX Idexx Laboratories
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0000874716-24-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-16 | 2024-02-14 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | +927 | 11.0K | +9% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | POLEWACZYK JAMES F | EVP | F - Tax | $560.56 | -279 | 10.7K | -3% | -$156.4K |
| DM | 2024-02-16 | 2024-02-14 | IDXX | POLEWACZYK JAMES F | EVP | M - OptEx | $0.00 | -927 | 660 | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | M | A | 216 | $0.00 | 10,405.23 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-14 | M | A | 126 | $0.00 | 10,189.23 | D | — | — | (F1) Includes 13.2470 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023. |
| 3 | Common | Common Stock | 2024-02-14 | M | A | 161 | $0.00 | 10,566.23 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-14 | M | A | 204 | $0.00 | 10,770.23 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-14 | F | D | 279 | $560.56 | 10,711.23 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-14 | M | A | 220 | $0.00 | 10,990.23 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 204 | $0.00 | 408 | D | — · — to — | 204 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| 8 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 161 | $0.00 | 160 | D | — · — to — | 161 Common Stock | (F4) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 9 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 216 | $0.00 | 0 | D | — · — to — | 216 Common Stock | (F3) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021. |
| 10 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 126 | $0.00 | 0 | D | — · — to — | 126 Common Stock | (F2) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020. |
| 11 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 220 | $0.00 | 660 | D | — · — to — | 220 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. |